(Q34187006)

31 July 2017

1 reference

title

Pregabalin: a new anxiolytic (English)

1 reference

31 July 2017

author name string

Bianca A Lauria-Horner

series ordinal

1

1 reference

31 July 2017

Robert B Pohl

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

published in

1 reference

31 July 2017

volume

12

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

663-672

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Social phobia. Comorbidity and morbidity in an epidemiologic sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

The new generation of GABA enhancers. Potential in the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

3-substituted GABA analogs with central nervous system activity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Pregabalin in patients with postoperative dental pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Effect of gabapentin-like compounds on development and maintenance of morphine-induced conditioned place preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

The effect of gabapentin on neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Reflex sympathetic dystrophy treated with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Cost-effectiveness of antiepileptic drugs in migraine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Open label gabapentin treatment for pain in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Vincristine-induced allodynia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

Effective treatment of orthostatic tremor with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.4.663

10.1517/13543784.12.4.663

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference